In-Chul Kim
Corporate Officer/Principal at KAINOS MEDICINE, INC.
Profile
In-Chul Kim is currently the President & Chief Executive Officer at National OncoVenture.
He is also the Vice Chairman at Kainos Medicine, Inc., the Director at Institut Pasteur Korea Research Foundation, and the Chief Strategic Officer at Kainos Medicine, Inc. Dr. Kim holds a doctorate degree from the University of Illinois.
In-Chul Kim active positions
| Companies | Position | Start |
|---|---|---|
| KAINOS MEDICINE, INC. | Corporate Officer/Principal | - |
Institut Pasteur Korea Research Foundation
 Institut Pasteur Korea Research Foundation BiotechnologyHealth Technology Institut Pasteur Korea Research Foundation provides research and development for the treatment of infectious and chronic diseases. It develops a technology-based approach to therapeutic development through cellular models, high content screening and medicinal chemistry. The company was founded on December 29, 2003 and is headquartered in Seongnam, South Korea. | Director/Board Member | - |
| National OncoVenture | Chief Executive Officer | - |
Training of In-Chul Kim
| University of Illinois | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| KAINOS MEDICINE, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Institut Pasteur Korea Research Foundation
Institut Pasteur Korea Research Foundation BiotechnologyHealth Technology Institut Pasteur Korea Research Foundation provides research and development for the treatment of infectious and chronic diseases. It develops a technology-based approach to therapeutic development through cellular models, high content screening and medicinal chemistry. The company was founded on December 29, 2003 and is headquartered in Seongnam, South Korea. | Health Technology |
| National OncoVenture |
- Stock Market
- Insiders
- In-Chul Kim
